|
ZBTB38 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.858400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.968200E-02 |
| Normal-vs-Stage2 |
1.017970E-01 |
| Normal-vs-Stage3 |
1.769960E-01 |
| Normal-vs-Stage4 |
9.769900E-02 |
| Stage1-vs-Stage2 |
6.130000E-01 |
| Stage1-vs-Stage3 |
9.342400E-01 |
| Stage1-vs-Stage4 |
7.257600E-01 |
| Stage2-vs-Stage3 |
7.454600E-01 |
| Stage2-vs-Stage4 |
8.726400E-01 |
| Stage3-vs-Stage4 |
8.524000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.203900E-02 |
| Normal-vs-AfricanAmerican |
6.815200E-04 |
| Normal-vs-Asian |
7.625200E-01 |
| Caucasian-vs-AfricanAmerican |
2.696300E-02 |
| Caucasian-vs-Asian |
4.048400E-01 |
| AfricanAmerican-vs-Asian |
7.401600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.974200E-02 |
| Normal-vs-Female |
1.663400E-01 |
| Male-vs-Female |
3.807800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.209600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.210630E-01 |
| Normal-vs-Age(61-80Yrs) |
5.569800E-02 |
| Normal-vs-Age(81-100Yrs) |
8.29669999999894E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.488600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.908200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.150300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.444400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.662320E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.379200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.134200E-01 |
| Normal-vs-Grade 2 |
1.878390E-01 |
| Normal-vs-Grade 3 |
6.448200E-04 |
| Normal-vs-Grade 4 |
7.304000E-01 |
| Grade 1-vs-Grade 2 |
8.249600E-01 |
| Grade 1-vs-Grade 3 |
2.855600E-01 |
| Grade 1-vs-Grade 4 |
8.608800E-01 |
| Grade 2-vs-Grade 3 |
3.029900E-02 |
| Grade 2-vs-Grade 4 |
5.825200E-01 |
| Grade 3-vs-Grade 4 |
7.821800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.620390E-02 |
| Normal-vs-ccB subtype |
7.841000E-01 |
| ccA subtype-vs-ccB subtype |
1.674280E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.133800E-01 |
| Normal-vs-N1 |
6.063400E-01 |
| N0-vs-N1 |
4.562400E-01 |
|
|
